×
About 209,862 results

ALLMedicine™ Cardiovascular Disease Center

Research & Reviews  97,445 results

Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy ...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16354
Hypertension (Dallas, Tex. : 1979); Vishram-Nielsen JKK, Kristensen AMD et. al.

Mar 1st, 2021 - It remains unclear which blood pressure (BP) characteristics best predict cardiovascular risk in different age groups and between sexes. We leveraged data from the MORGAM (MONICA [Monitoring of Trends and Determinants in Cardiovascular Disease], R...

Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16689
Hypertension (Dallas, Tex. : 1979); Parcha V, Malla G et. al.

Mar 1st, 2021 - The 2017 American College of Cardiology/American Heart Association high blood pressure (BP) guidelines recommend risk assessment of atherosclerotic cardiovascular disease to inform hypertension treatment in adults with elevated BP or low-risk stag...

Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Ad...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16784
Hypertension (Dallas, Tex. : 1979); Lee H, Yano Y et. al.

Mar 1st, 2021 - Treatment and control rates for high blood pressure are unsatisfactory in young adults. Adherence to pharmacological treatment is alarmingly low, with absence of data on its consequences in young adults with hypertension. We investigated the assoc...

Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independent...
https://doi.org/10.1161/HYPERTENSIONAHA.120.14851
Hypertension (Dallas, Tex. : 1979); Argunhan F, Thapa D et. al.

Mar 1st, 2021 - The neuropeptide CGRP (calcitonin gene-related peptide) is a potent vasodilator, with a cardioprotective role, although the precise mechanisms are unclear. Here we show the ability of endogenous and exogenous CGRP to restore blood pressure, when n...

Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England: A Model...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16649
Hypertension (Dallas, Tex. : 1979); Alonso S, Tan M et. al.

Mar 1st, 2021 - The United Kingdom was among the first countries to introduce a salt reduction program in 2003 to reduce cardiovascular disease (CVD) incidence risk. Despite its initial success, the program has stalled recently and is yet to achieve national and ...

see more →

Guidelines  579 results

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
https://www.bmj.com/content/372/bmj.n135
BMJ Herrett E, .

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vacci...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623
Journal of the American College of Cardiology; Driggin E, Morris AA et. al.

Feb 15th, 2021 - ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization.|2021|Driggin E,Morris AA,Maddox TM,Mullen JB,Ferdinand KC,|

Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opin...
https://doi.org/10.1016/j.jacc.2020.12.003
Journal of the American College of Cardiology; Brauer M, Casadei B et. al.

Feb 1st, 2021 - Although the attention of the world and the global health community specifically is deservedly focused on the COVID-19 pandemic, other determinants of health continue to have large impacts and may also interact with COVID-19. Air pollution is one ...

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy i...
https://doi.org/10.1016/j.jacc.2020.09.011
Journal of the American College of Cardiology; Kumbhani DJ, Cannon CP et. al.

Nov 30th, 2020 - 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Re...

see more →

Drugs  339 results see all →

Clinicaltrials.gov  103,643 results

Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy ...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16354
Hypertension (Dallas, Tex. : 1979); Vishram-Nielsen JKK, Kristensen AMD et. al.

Mar 1st, 2021 - It remains unclear which blood pressure (BP) characteristics best predict cardiovascular risk in different age groups and between sexes. We leveraged data from the MORGAM (MONICA [Monitoring of Trends and Determinants in Cardiovascular Disease], R...

Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16689
Hypertension (Dallas, Tex. : 1979); Parcha V, Malla G et. al.

Mar 1st, 2021 - The 2017 American College of Cardiology/American Heart Association high blood pressure (BP) guidelines recommend risk assessment of atherosclerotic cardiovascular disease to inform hypertension treatment in adults with elevated BP or low-risk stag...

Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Ad...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16784
Hypertension (Dallas, Tex. : 1979); Lee H, Yano Y et. al.

Mar 1st, 2021 - Treatment and control rates for high blood pressure are unsatisfactory in young adults. Adherence to pharmacological treatment is alarmingly low, with absence of data on its consequences in young adults with hypertension. We investigated the assoc...

Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independent...
https://doi.org/10.1161/HYPERTENSIONAHA.120.14851
Hypertension (Dallas, Tex. : 1979); Argunhan F, Thapa D et. al.

Mar 1st, 2021 - The neuropeptide CGRP (calcitonin gene-related peptide) is a potent vasodilator, with a cardioprotective role, although the precise mechanisms are unclear. Here we show the ability of endogenous and exogenous CGRP to restore blood pressure, when n...

Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England: A Model...
https://doi.org/10.1161/HYPERTENSIONAHA.120.16649
Hypertension (Dallas, Tex. : 1979); Alonso S, Tan M et. al.

Mar 1st, 2021 - The United Kingdom was among the first countries to introduce a salt reduction program in 2003 to reduce cardiovascular disease (CVD) incidence risk. Despite its initial success, the program has stalled recently and is yet to achieve national and ...

see more →

News  7,835 results

Ketone Supplementation: A Novel Intervention for CVD?
https://www.medscape.com/viewarticle/946647

Feb 28th, 2021 - Ketone bodies may have therapeutic benefits for patients with cardiovascular disease (CVD), regardless of the method used to increase their presence in the heart, a new review suggests. The authors looked at the current body of experimental and cl...

Long-term CPAP Use Linked With More Physical Activity
https://www.medscape.com/viewarticle/946400

Feb 23rd, 2021 - Long-term use of continuous positive airway pressure (CPAP) was associated with higher self-reported physical activity levels in adults with co-occurring obstructive sleep apnea (OSA) and cardiovascular disease (CVD), in new research. "The aim of ...

Big Data 'Clinch' Link Between High Glycemic Index Diets and CVD
https://www.medscape.com/viewarticle/946406

Feb 23rd, 2021 - People who mostly ate foods with a low glycemic index had a lower likelihood of premature death and major cardiovascular disease (CVD) events compared with those whose diet included more "poor quality" food with a high glycemic index. The results ...

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
https://www.bmj.com/content/372/bmj.n135
BMJ Herrett E, .

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

Wide Swings in Blood Glucose Linked to More CVD in Diabetes
https://www.medscape.com/viewarticle/945645

Feb 10th, 2021 - Patients with type 2 diabetes and the highest level of variability in their A1c levels over 2 years had significantly more first cardiovascular disease (CVD) events than similar patients with less A1c variability, in a retrospective analysis of mo...

see more →

Patient Education  21 results see all →